Core Insights - Kenvue reported $3.84 billion in revenue for the quarter ended June 2025, reflecting a year-over-year decline of 4% and an EPS of $0.29 compared to $0.32 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $3.86 billion by 0.51%, while the EPS exceeded the consensus estimate of $0.28 by 3.57% [1] Financial Performance Metrics - Kenvue's net sales in the Self Care segment were $1.56 billion, slightly below the average estimate of $1.6 billion, marking a year-over-year decline of 4.9% [4] - In the Essential Health segment, net sales were $1.23 billion, matching the average estimate, but reflecting a year-over-year decrease of 2.9% [4] - The Skin Health and Beauty segment reported net sales of $1.06 billion, surpassing the average estimate of $1.04 billion, with a year-over-year decline of 4% [4] Stock Performance - Kenvue shares have returned +3.3% over the past month, outperforming the Zacks S&P 500 composite's +1.2% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
Kenvue (KVUE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates